Bold Business Logo

Venture Capital for Female Entrepreneurs—Aminta Ventures Brings Bold Changes!

As Bold Business has previously reported, the venture capital space is still dominated by male entrepreneurs. Even today,  there is significantly less investment in companies led by women, even when studies show that women-led start-ups outperform those run by males. In fact, in 2017, women only accounted for 8 percent among the top 100 venture capital firms. (Women-assumed partner roles at accelerators and corporate VCs have increased to a paltry 15 percent since 2016.) Similarly, investments in female-led companies have plateaued as a result of the shortage of women in VC. However, a new Miami based company is trying to change the landscape of venture capital and startups in South Florida. Aminta Ventures addresses the root issue by deeply cultivating a new approach for venture capital for female entrepreneurs.

Aminta Ventures— “For Women, By Women”

Seasoned venture capitalists Julia Ford-Carther, Mary Anderson, Carolina Canida, Rosario Chozas, Alia Mahmoud, Nelly M. Farra, Natalia Martinez-Kalinina, and Deborah Johnson established Aminta Ventures. At around the same time that they built Aminta, women made up just 25 percent of angel investors in 2016. Male investors continued to disregard female founders and choose to invest in male founders instead.

This attitude toward venture capital for female entrepreneurs becomes unreliable and eventually creates an unbalanced ecosystem. Only companies born out of male perspectives, needs, and ambitions gain support. Consequently, the female market, perspectives, needs, ambitions, and innovations receive the cold shoulder.

Encouraging Female Angel Investors

Based on a research in 2018, if investors want to succeed by relying on data, they should be investing in women. Appropriately, the influential women of Aminta Ventures want to upend this long-standing tradition of excluding women in business. They want to dismantle the barriers to investing and allow inclusive participation, education, and training of women in venture capital.

Aminta aims to foster growing generations of female angel investors who not only validate female opportunities but also know how to harness this power to make significant changes in entrepreneurship and the innovation sectors.

The Angel Investment Community for Women Entrepreneurs

To engage female venture capitalists, Aminta hosts yearly flagship events with South Florida investment groups and other partners. These events include a women-funded pitch night and an angel investment boot camp. Apart from these, Aminta also organizes happy hour discussions featuring entrepreneurship and investment experts.

Some of their past events featured leaders such as Dr. Kathy Fields of Proactiv Solutions and Rodan + Fields, Trina Spear of FIGS, and Jocelyn Cortez-Young of Minerva Capital Group.

In these events, participants learn how to invest and support entrepreneurs and companies in their early stages. Some members also engage in philanthropy and mentoring or participate in the boards of different organizations.

The Road Toward a Better Space for Women in Venture Capital

“Given the powerful role that women play in leading a myriad of business, philanthropic, and community efforts in our city, it is a natural extension to think of them playing a strong role in the progress of our entrepreneurship and innovation sector,” said Natalia Martinez-Kalinina, one of the co-founders of Aminta. She also added, “Currently, we don’t necessarily see much parity reflected in the makeup of our local investor network, so our intention is to capacitate and shepherd more women to throw their hat in the ring and join the existing momentum.”

Aminta Ventures is expanding the space of venture capital for female entrepreneurs to explore and create opportunities. It’s an effective way of gathering powerful and influential female leaders who are firm on making a bold difference towards gender equality in venture capital.

Long Way to Go for Venture Capital for Female Entrepreneurs

While Aminta Ventures and other female-led organizations all over America advocate for the visibility of women in venture capital, the figures have not improved much at all in 2018.

Less than 10 percent of decision-makers in VC companies are women. Also, 74 percent of VC firms don’t even have women investors. Essentially, women are still a minority in venture capital, and the growth of women-led startups is stunted. Experts point to the same issue—the lack of female financiers—as the main reason why women entrepreneurs don’t get attention and funding.

Apart from empowering women to decision-making roles in venture capital, there is a need for a paradigm shift as to how women entrepreneurs are treated. Research from the Academy of Management showed that investors ask different questions based on gender. Investors ask male entrepreneurs how they would win and female entrepreneurs what they would do to avoid losing. This attitude perpetuates the outdated idea that women are inferior business leaders compared to men and, thus, have more to prove than men. This unequal footing at the beginning stages of investments leaves very little space in venture capital for female entrepreneurs.

Aminta Ventures and Venture Capital for Female Entrepreneurs

Aminta Ventures is an integral cog in the system working boldly to bring equality in venture capital. They are putting the spotlight on women to show that their business investment insights and contributions hold as much—if not more—value as men’s. There must be more support for Aminta Ventures to make a substantial impact on women startup funding.

Women from South Florida, as well as from the rest of the country, must work together to create an ecosystem bound by the principle of equality. Aminta Ventures is an exemplary organization in the United States. Indeed, it brings to light the problems and solutions towards gender parity in an industry still harboring outdated ideals.

Sources:

Women’s share of venture capital remains flat

New organization Aminta supports women investors, plans workshop

3D Printing and Stem Cells: Tremendous Hope for Dozens of Neurological Disorders

In the United States today, over 120,000 people await organ donation for life-threatening illnesses. Unfortunately, twenty-two people die each day because demand far outweighs supply. However, that may soon change. Radically, bold moves in stem cell research and 3D printing are offering new hope that may eliminate the need for organ donation. Additionally, these same discoveries have tremendous implications for neurological disorders. 3D printing for medical use and neurological stem cell technology could eventually be a mainstream technique. Several innovative companies and bioengineering experts are leading the way.

Understanding 3D Printing for Medical Use

The use of neurological stem cell technology is not necessarily new. In fact, researchers have actively studied stem cell research for Parkinson’s disease and spinal cord injuries for many years. But 3D printing for medical use is accelerating the potential of neurological stem cell technology. 

There were injections or surgical implants of stem cells available in the past with the hope they would survive and function. However,  there were limitations to the positive outcomes from these studies. With 3D printing for medical use, however, results look to be much more promising and exciting.

The printing “bio-ink” for medical 3D printing are stem cells. Of course, the ink requires a special kind of “paper” for printing. Interestingly, bioengineers utilize other types of structures for the printing of neurological stem cell technology. The resultant 3D structure then allows these stem cells to develop into specific neuronal tissues or even neurological organs themselves  And because stem cells come from the person being treated, tissue rejection chances are much less.

Bold Potential for Common Brain Diseases

Brain transplants are not on the horizon…yet. But 3D printing for medical use offers tremendous potential for treating common neurological disorders in the very near future. Specifically, neurological stem cell technology could be a key to treatments in Parkinson’s disease, epilepsy, brain trauma, and even schizophrenia. In essence, 3D printing for medical use could allow neurological stem cell technology to replace dysfunction or degenerative neurons.

At the University of Wollongong in Australia, researchers have been pursuing this approach for over a year. They printed pluripotent stem cells onto a 3D scaffold to create neurons that made specific brain chemicals. The goal is to then place these cells in the brains of patients with specific conditions lacking these neurotransmitters. This is how neurological stem cell technology could restore function to a variety of neurological illnesses.

Major Headway for Spinal Cord Injury Treatment

In addition to treating neurological diseases of the brain, neurological stem cell technology also offers promise for spinal cord injuries. In the U.S., over 17,000 new spinal cord injuries occur each year with notable disabilities. However, at the University of Minnesota, researchers have successfully used 3D printing for medical use to help these individuals.

Funded by Conquer Paralysis Now, specialized stem cells are printed onto a silicone structure. This structure is then inserted as a “bridge” between healthy spinal cord areas. Researchers are finding that roughly three-quarters of the stem cells are surviving, which is a marked improvement. Thus, this form of neuromedicine could offer a radical new option of care.

Advancing Care Through Research

Indeed, 3D printing for medical use and neurological stem cell technology is exciting in terms of new disease treatments. But other companies are advancing discoveries by facilitating neurological research. Celprogen, Inc., is recognized as a bold business leader in stem cell research and therapeutics. Recently, the company successfully used 3D printing for medical use to recreate an entire brain from stem cells.

While this does not offer any direct treatment options, it does enable researchers to have access to brain tissue for study. This means that there is an acceleration in the capacity to understand neurological diseases and research the effects of new drugs. For example, stem cells from a Parkinson’s disease patient could recreate a “Parkinson’s brain” for active research. Not only does this avoid animal research, it speeds up the investigative process as well.

Challenges Ahead for Neurological Stem Cell Technology

Several obstacles exist for 3D printing for medical use. For one, all tissues need blood circulation. Matching up a person’s existing blood vessels with that of 3D-printed tissues poses a challenge. Likewise, some stem cell types have the potential for developing into tumors called teratomas. However, ongoing research is actively looking to solve these problems. And thus far, there clearly spells progress. Given the speed at which these developments are proceeding, 3D printing for medical use is likely right around the corner.

How can we help?